Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
15th Jan 20247:00 amRNSIssue of Equity
12th Jan 20242:51 pmRNSNet Asset Value(s)
5th Jan 20245:29 pmRNSNet Asset Value(s)
3rd Jan 202412:44 pmRNSNet Asset Value(s)
2nd Jan 20241:58 pmRNSTotal Voting Rights
21st Dec 20233:45 pmRNSNet Asset Value(s)
20th Dec 20233:56 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 202311:01 amRNSNet Asset Value(s)
4th Dec 202310:44 amRNSNet Asset Value(s)
1st Dec 202310:25 amRNSTotal Voting Rights
30th Nov 20234:02 pmRNSDividend Declaration
28th Nov 202312:46 pmRNSTransaction in Own Shares
27th Nov 202312:16 pmRNSDirector/PDMR Shareholding
27th Nov 20239:34 amRNSIssue of Equity
24th Nov 20234:23 pmRNSNet Asset Value(s)
20th Nov 202310:19 amRNSNet Asset Value(s)
17th Nov 20234:46 pmRNSTransaction in Own Shares
13th Nov 20239:31 amRNSNet Asset Value(s)
6th Nov 202312:27 pmRNSTransaction in Own Shares
2nd Nov 20239:34 amRNSNet Asset Value(s)
1st Nov 202310:01 amRNSTotal Voting Rights
30th Oct 20233:52 pmRNSTransaction in Own Shares
30th Oct 202310:19 amRNSNet Asset Value(s)
23rd Oct 20234:50 pmRNSNet Asset Value(s)
19th Oct 202311:31 amRNSTransaction in Own Shares
16th Oct 202311:43 amRNSTransaction in Own Shares
13th Oct 20235:41 pmRNSNet Asset Value(s)
9th Oct 202312:54 pmRNSTransaction in Own Shares
6th Oct 20235:23 pmRNSNet Asset Value(s)
6th Oct 20237:01 amRNSDividend Declaration
6th Oct 20237:00 amRNSHalf-year Report
3rd Oct 202312:07 pmRNSNet Asset Value(s)
2nd Oct 202310:31 amRNSTotal Voting Rights
25th Sep 20239:53 amRNSNet Asset Value(s)
22nd Sep 20231:11 pmRNSTransaction in Own Shares
18th Sep 202312:10 pmRNSNet Asset Value(s)
14th Sep 202312:17 pmRNSTransaction in Own Shares
11th Sep 20239:21 amRNSNet Asset Value(s)
5th Sep 202311:24 amRNSCompliance with Market Abuse Regulation
4th Sep 202310:43 amRNSNet Asset Value(s)
1st Sep 202311:33 amRNSTotal Voting Rights
31st Aug 20234:44 pmRNSTransaction in Own Shares
25th Aug 20233:20 pmRNSNet Asset Value(s)
18th Aug 20235:18 pmRNSNet Asset Value(s)
15th Aug 20234:13 pmRNSTransaction in Own Shares
11th Aug 20234:20 pmRNSNet Asset Value(s)
4th Aug 20234:17 pmRNSNet Asset Value(s)
2nd Aug 20234:18 pmRNSTransaction in Own Shares
1st Aug 20234:49 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.